Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Express Scripts
Baxter
Harvard Business School

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Mocetinostat


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Mocetinostat?

Mocetinostat is an investigational drug.

There have been 11 clinical trials for Mocetinostat. The most recent clinical trial was a Phase 2 trial, which was initiated on November 12th 2015.

The most common disease conditions in clinical trials are Carcinoma, Lymphoma, and Melanoma. The leading clinical trial sponsors are Mirati Therapeutics Inc., Memorial Sloan Kettering Cancer Center, and MethylGene Inc.

There are six hundred and eight US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Mocetinostat
TitleSponsorPhase
Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaMirati Therapeutics Inc.Phase 1
Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaPhase One FoundationPhase 1
Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaJonsson Comprehensive Cancer CenterPhase 1

See all Mocetinostat clinical trials

Clinical Trial Summary for Mocetinostat

Top disease conditions for Mocetinostat
Top clinical trial sponsors for Mocetinostat

See all Mocetinostat clinical trials

US Patents for Mocetinostat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mocetinostat ⤷  Try it Free Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Selecta Biosciences, Inc. (Watertown, MA) ⤷  Try it Free
Mocetinostat ⤷  Try it Free Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor Pharmacyclics LLC (Sunnyvale, CA) ⤷  Try it Free
Mocetinostat ⤷  Try it Free Histone deacetylase inhibitors and methods for use thereof REACTION BIOLOGY CORP. (Malvern, PA) ⤷  Try it Free
Mocetinostat ⤷  Try it Free Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA) ⤷  Try it Free
Mocetinostat ⤷  Try it Free Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Mocetinostat

Drugname Country Document Number Estimated Expiration Related US Patent
Mocetinostat Australia AU2011279250 2030-07-12 ⤷  Try it Free
Mocetinostat Australia AU2012249401 2030-07-12 ⤷  Try it Free
Mocetinostat Australia AU2012249419 2030-07-12 ⤷  Try it Free
Mocetinostat Australia AU2012249493 2030-07-12 ⤷  Try it Free
Mocetinostat Australia AU2012249537 2030-07-12 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Dow
Express Scripts
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.